PulmCCM

PulmCCM

Share this post

PulmCCM
PulmCCM
Continuous meropenem infusion for critically ill patients with sepsis (MERCY trial)
Copy link
Facebook
Email
Notes
More

Continuous meropenem infusion for critically ill patients with sepsis (MERCY trial)

PulmCCM's avatar
PulmCCM
Jul 16, 2023
∙ Paid

Share this post

PulmCCM
PulmCCM
Continuous meropenem infusion for critically ill patients with sepsis (MERCY trial)
Copy link
Facebook
Email
Notes
More
Share

Antibiotics have a time-dependent effect on bacteria, so maintaining bacteriocidal concentrations of antibiotics should theoretically help subdue infections better than intermittent dosing. A 2018 meta-analysis reviewed here suggested that prolonged infusion of antipseudomonal beta-lactams reduced mortality by 30% compared with shorter infusions, and mo…

Keep reading with a 7-day free trial

Subscribe to PulmCCM to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 PulmCCM LLC
Publisher Terms
Substack
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More